FY2029 Earnings Forecast for Bio-Path Issued By Roth Capital
Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital issued their FY2029 earnings estimates for Bio-Path in a note issued to investors on Tuesday, June 3rd. Roth Capital analyst J. Aschoff anticipates that the company will post earnings of $2.14 per share for the year. The consensus estimate for Bio-Path’s current full-year earnings is […]
